Essure Organ Perforation Experienced By One Out of Every 50 Women Receiving Sterilization Device, FDA Interim Analysis Finds
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Study of Recalled Essure Implant Continues to Lose Participants, But FDA Reports Measures to Fix Data are Working Women continue to drop out of an FDA-required long-term study, with nearly 16% of all Essure patients having the devices surgically removed, even though it was designed to be a permanent form of birth control November 1, 2023 Irvin Jackson Add Your Comments Federal regulators have released new data on recalled Essure birth control implants, indicating that it has been necessary for Bayer to take steps to improve data from a government-mandated study, due to high dropout rates among women who received Essure before it was recalled from the market. Essure is a permanent birth control implant, involving flexible coils inserted into the fallopian tubes during an outpatient procedure. The device was intended to cause scar tissue to develop, which would block the tubes and prevent insemination. However, thousands of women experienced painful and debilitating Essure complications, including device fractures, migration, and organ perforation. In 2018, the U.S. Food and Drug Administration (FDA) announced that Essure implants were being removed from the market. As part of the Essure recall, the federal regulators ordered Bayer to conduct post-marketing surveillance of women who had received the implant, to get a better sense of the long-term risks associated with the birth control device. Essure Interim Study Results On October 30, the agency released an Essure implant update, providing interim results of the ongoing post-marketing surveillance study, involving three years of follow-up on women who had received the implant. About this time last year, the FDA had claimed progress on the Essure study was “inadequate”, due to a high dropout rate among participants. The dropout rates were so high that it was leading to poor data, with 47.4% of Essure patients having discontinued the study at that time, the FDA noted. However, in this update, the agency says the situation with the Essure post-marketing study has improved, upgrading the status from “inadequate” to “ongoing”, even though the drop out rate has now exceeded 51%. “At the request of FDA in 2022, Bayer developed and implemented additional strategies to improve follow up in the study. The current study status is ‘ongoing’ because the progress of the study is consistent with the study plan,” the FDA update notes. “The FDA will continue to monitor lost to follow-up rates in the study and work with Bayer to take additional measures as needed.” Learn More About Essure Implant Lawsuit Problems with Essure birth control implant may cause painful complications. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Essure Implant Lawsuit Problems with Essure birth control implant may cause painful complications. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Essure Complication and Removal Rates The FDA indicates that data collected in June determined that the rate of Essure device removal rates for any given reason was about 15.7%. Those who got the implant believing it would be a permanent form of birth control had the device removed about 12.3% of the time, the FDA determined. Previous analyses have found that unintentional organ perforation rates with the Essure were 1.9%, nearly double the 1.1% rate linked to laparoscopic tubal sterilization: another form of permanent birth control. A final analysis of the data will be made after researchers conduct a five-year follow-up with Essure patients in about two years, the agency indicates. In March 2022, the FDA indicated it has received a total of 67,643 medical device reports linked to the Essure implant. While most reports received between 2013 and 2015 were voluntary submissions from women who received Essure implants, in 2021 98% of the 3,701 reports received by the FDA were submitted by Bayer. Of those, 85% were related to device removal, the FDA noted, and most were linked to litigation. The manufacturer recalled the birth control implant only after thousands of Essure lawsuits were filed by women who experienced adverse health effects while implanted with the birth control device. After several years in the court system, Bayer announced in 2020 that it would pay $1.6 billion to settle about 90% of all Essure cases pending at that time. However, with approximately 750,000 women worldwide implanted with the device, and 70% of those Essure procedures occurring in the United States, it is expected that additional lawsuits will be filed in the coming years as women continue to experience complications. Tags: Bayer, Birth Control, Essure Image Credit: | More Essure Lawsuit Stories Progress of Essure Birth Control Implant Post-Marketing Study “Inadequate,” FDA Warns Bayer October 11, 2022 85% of Bayer Essure Adverse Event Reports Submitted Last Year Linked to Device Removal: FDA March 16, 2022 Essure Organ Perforation Experienced By One Out of Every 50 Women Receiving Sterilization Device, FDA Interim Analysis Finds February 17, 2022 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (Posted: 2 days ago) A hairdresser who has worked for nearly 40 years in the industry says her constant exposure to hair dye led to a bladder cancer diagnosis. MORE ABOUT: HAIR DYE LAWSUITSalon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)Hair Dye Cancer Lawsuit Filed Over Wrongful Death of Salon Professional (04/11/2025) First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (Posted: 2 days ago) An Oxbryta class action lawsuit has been scheduled for trial in August 2027, but must first survive a motion to dismiss filed by manufacturers. MORE ABOUT: OXBRYTA LAWSUITMalpractice Lawsuit Alleges Side Effects of Oxbryta Caused Untimely Death (04/15/2025)At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics (03/14/2025)After Recalling Oxbryta, Pfizer Seeks Dismissal of Class Action Brought by Former Users (03/07/2025) Court Urged To Combine 5 AFFF Lawsuits For First MDL Bellwether Trial (Posted: 3 days ago) Plaintiffs have asked the judge presiding over all AFFF lawsuits to consolidate five claims involving kidney cancer and testicular cancer injuries for the first bellwether trial in the federal MDL. MORE ABOUT: AFFF LAWSUITAdditional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (04/29/2025)Firefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)
Progress of Essure Birth Control Implant Post-Marketing Study “Inadequate,” FDA Warns Bayer October 11, 2022
85% of Bayer Essure Adverse Event Reports Submitted Last Year Linked to Device Removal: FDA March 16, 2022
Essure Organ Perforation Experienced By One Out of Every 50 Women Receiving Sterilization Device, FDA Interim Analysis Finds February 17, 2022
Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (Posted: 2 days ago) A hairdresser who has worked for nearly 40 years in the industry says her constant exposure to hair dye led to a bladder cancer diagnosis. MORE ABOUT: HAIR DYE LAWSUITSalon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)Hair Dye Cancer Lawsuit Filed Over Wrongful Death of Salon Professional (04/11/2025)
First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (Posted: 2 days ago) An Oxbryta class action lawsuit has been scheduled for trial in August 2027, but must first survive a motion to dismiss filed by manufacturers. MORE ABOUT: OXBRYTA LAWSUITMalpractice Lawsuit Alleges Side Effects of Oxbryta Caused Untimely Death (04/15/2025)At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics (03/14/2025)After Recalling Oxbryta, Pfizer Seeks Dismissal of Class Action Brought by Former Users (03/07/2025)
Court Urged To Combine 5 AFFF Lawsuits For First MDL Bellwether Trial (Posted: 3 days ago) Plaintiffs have asked the judge presiding over all AFFF lawsuits to consolidate five claims involving kidney cancer and testicular cancer injuries for the first bellwether trial in the federal MDL. MORE ABOUT: AFFF LAWSUITAdditional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (04/29/2025)Firefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)